Analysts' ratings for American Tower (NYSE:AMT) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The following table encapsulates their recent ratings, offering a ...

Tower Semiconductor (NASDAQ:TSEM – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Wedbush in a research report issued on Tuesday,RTT News reports. They currently ...

NASDAQ:TSEM opened at $48.21 on Tuesday. Tower Semiconductor has a one year low of $29.62 and a one year high of $55.31. The company has a market cap of $5.34 billion, a P/E ratio of 26.06 and a ...

Tower Semiconductor Ltd. (NASDAQ:TSEM), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS. While good news for ...

Tower Semiconductor Ltd. (NASDAQ:TSEM), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS. While good news for ...

Kilroy CEO Angela Aman said during the earnings call that Kilroy executed an “early termination with an existing tenant” that was leasing space through late 2025 to make way for Walmart. She said ...

StockNews.com upgraded shares of Baozun (NASDAQ:BZUN – Free Report) from a hold rating to a buy rating in a research report sent to investors on Sunday. Separately, Citigroup upped their price ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has received a consensus recommendation of “Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports ...

JFrog (NASDAQ:FROG – Get Free Report) had its price objective upped by research analysts at Stifel Nicolaus from $35.00 to $45.00 in a research report issued to clients and investors on ...

StockNews.com began coverage on shares of First Bancshares (NASDAQ:FBMS – Free Report) in a research report sent to investors on Monday. The brokerage issued a sell rating on the bank’s stock. FBMS ...

Equities researchers at Wedbush decreased their FY2025 earnings estimates for shares of Replimune Group in a research report ...